Limits...
The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps.

Hu J, Yuan R - Med. Sci. Monit. (2011)

Bottom Line: We detected the protein expression levels of IPO13, telomerase, CD146, caspase-3, bcl-2 and bax in EPs using S-P (Streptavidin-Peroxidase) immunohistochemistry.Western blotting was performed to determine the levels of importin13 and bcl-2 proteins in EPs.The expression levels of IPO13, c-kit, telomerase, caspase3, and bax were lower in the EP tissue compared to normal endometrial tissue during the proliferation and secretion phases of the menstrual cycle (p<0.05).

View Article: PubMed Central - PubMed

Affiliation: Department of Obstetrics and Gynecology, 1st Affiliated Hospital, Chongqing Medical University, Chongqing, China.

ABSTRACT

Background: To investigate the expression levels of importin13 (IPO13), c-kit, CD146, telomerase, caspase-3, bcl-2 and bax in endometrial polyps (EPs).

Material/methods: We detected the mRNA expression levels of IPO13, c-kit, bcl-2 and bax in endometrial polyps (EPs) using real-time PCR. We detected the protein expression levels of IPO13, telomerase, CD146, caspase-3, bcl-2 and bax in EPs using S-P (Streptavidin-Peroxidase) immunohistochemistry. Western blotting was performed to determine the levels of importin13 and bcl-2 proteins in EPs.

Results: The expression levels of IPO13, c-kit, telomerase, caspase3, and bax were lower in the EP tissue compared to normal endometrial tissue during the proliferation and secretion phases of the menstrual cycle (p<0.05). The expression of CD146 was decreased in the EP tissue compared to the normal endometrial tissue during the proliferation phase of the menstrual cycle (p<0.05). The expression of bcl-2 was increased in the EP tissue compared to the normal endometrial tissue during the proliferation and secretion phases of the menstrual cycle (p<0.05).

Conclusions: The expression levels of IPO13, c-kit, telomerase, caspase3, and bax were decreased; however, the expression of bcl-2 was increased in the EP tissue compared to the normal endometrial tissue. These findings suggest that the development of EPs is associated with the deregulated activities of the endometrial stem/progenitor cells and the decreased apoptosis of endometrial cells, with the latter being the major factor involved in the development of EPs.

Show MeSH

Related in: MedlinePlus

The mRNA expression of IPO13, c-kit, bcl-2 and bax was detected by real-time PCR. (A) Control endometrium at the proliferation phase. (IB) Control endometrium at the secretion phase. (IC) EP at the proliferation phase. (ID) EP at the secretion phase. (IIA) Control endometrium at the proliferation phase. (IIB) Control endometrium at the secretion phase. (IIC) EP at the proliferation phase. (IID) EP at the secretion phase. (IIIA) Control endometrium at the proliferation phase. (IIIB) Control endometrium at the secretion phase. (IIIC) EP at the proliferation phase. (IIID) EP at the secretion phase. (IVA) Control endometrium at the proliferation phase. (IVB) Control endometrium at the secretion phase. (IVC) EP at the proliferation phase. (IVD) EP at the secretion phase. ** p<0.05 (vs. control endometrium at the secretion phase); error bars, SEM.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3539613&req=5

f4-medscimonit-17-8-br221: The mRNA expression of IPO13, c-kit, bcl-2 and bax was detected by real-time PCR. (A) Control endometrium at the proliferation phase. (IB) Control endometrium at the secretion phase. (IC) EP at the proliferation phase. (ID) EP at the secretion phase. (IIA) Control endometrium at the proliferation phase. (IIB) Control endometrium at the secretion phase. (IIC) EP at the proliferation phase. (IID) EP at the secretion phase. (IIIA) Control endometrium at the proliferation phase. (IIIB) Control endometrium at the secretion phase. (IIIC) EP at the proliferation phase. (IIID) EP at the secretion phase. (IVA) Control endometrium at the proliferation phase. (IVB) Control endometrium at the secretion phase. (IVC) EP at the proliferation phase. (IVD) EP at the secretion phase. ** p<0.05 (vs. control endometrium at the secretion phase); error bars, SEM.

Mentions: IPO13 mRNA expression was significantly increased in the proliferative endometrium of the control group compared to that in the EP patients (p<0.05). IPO13 mRNA expression was significantly increased in the secretory endometrium of the control group compared to that in the EP patients (p<0.05) (Figure 4I). The c-kit mRNA expression was increased about 1.5-fold in the proliferative endometrium of the control group compared to that in the EP patients (p<0.05). The c-kit mRNA expression was increased about 3-fold in the secretory endometrium of the control group compared to that in the EP patients (p<0.05) (Figure 4II). The bcl-2 mRNA expression was significantly increased in the proliferative endometrium of the EP patients compared to that in the control group (p<0.05). The bcl-2 mRNA expression was significantly increased in the secretory endometrium of the EP patients compared to that in the control group (p<0.05) (Figure 4III). The bax mRNA expression was significantly increased in the proliferative endometrium of the control group compared to that in the EP patients (p<0.05). The bax mRNA expression was significantly increased in the secretory endometrium of the control group compared to that in the EP patients (p<0.05) (Figure 4IV).


The expression levels of stem cell markers importin13, c-kit, CD146, and telomerase are decreased in endometrial polyps.

Hu J, Yuan R - Med. Sci. Monit. (2011)

The mRNA expression of IPO13, c-kit, bcl-2 and bax was detected by real-time PCR. (A) Control endometrium at the proliferation phase. (IB) Control endometrium at the secretion phase. (IC) EP at the proliferation phase. (ID) EP at the secretion phase. (IIA) Control endometrium at the proliferation phase. (IIB) Control endometrium at the secretion phase. (IIC) EP at the proliferation phase. (IID) EP at the secretion phase. (IIIA) Control endometrium at the proliferation phase. (IIIB) Control endometrium at the secretion phase. (IIIC) EP at the proliferation phase. (IIID) EP at the secretion phase. (IVA) Control endometrium at the proliferation phase. (IVB) Control endometrium at the secretion phase. (IVC) EP at the proliferation phase. (IVD) EP at the secretion phase. ** p<0.05 (vs. control endometrium at the secretion phase); error bars, SEM.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3539613&req=5

f4-medscimonit-17-8-br221: The mRNA expression of IPO13, c-kit, bcl-2 and bax was detected by real-time PCR. (A) Control endometrium at the proliferation phase. (IB) Control endometrium at the secretion phase. (IC) EP at the proliferation phase. (ID) EP at the secretion phase. (IIA) Control endometrium at the proliferation phase. (IIB) Control endometrium at the secretion phase. (IIC) EP at the proliferation phase. (IID) EP at the secretion phase. (IIIA) Control endometrium at the proliferation phase. (IIIB) Control endometrium at the secretion phase. (IIIC) EP at the proliferation phase. (IIID) EP at the secretion phase. (IVA) Control endometrium at the proliferation phase. (IVB) Control endometrium at the secretion phase. (IVC) EP at the proliferation phase. (IVD) EP at the secretion phase. ** p<0.05 (vs. control endometrium at the secretion phase); error bars, SEM.
Mentions: IPO13 mRNA expression was significantly increased in the proliferative endometrium of the control group compared to that in the EP patients (p<0.05). IPO13 mRNA expression was significantly increased in the secretory endometrium of the control group compared to that in the EP patients (p<0.05) (Figure 4I). The c-kit mRNA expression was increased about 1.5-fold in the proliferative endometrium of the control group compared to that in the EP patients (p<0.05). The c-kit mRNA expression was increased about 3-fold in the secretory endometrium of the control group compared to that in the EP patients (p<0.05) (Figure 4II). The bcl-2 mRNA expression was significantly increased in the proliferative endometrium of the EP patients compared to that in the control group (p<0.05). The bcl-2 mRNA expression was significantly increased in the secretory endometrium of the EP patients compared to that in the control group (p<0.05) (Figure 4III). The bax mRNA expression was significantly increased in the proliferative endometrium of the control group compared to that in the EP patients (p<0.05). The bax mRNA expression was significantly increased in the secretory endometrium of the control group compared to that in the EP patients (p<0.05) (Figure 4IV).

Bottom Line: We detected the protein expression levels of IPO13, telomerase, CD146, caspase-3, bcl-2 and bax in EPs using S-P (Streptavidin-Peroxidase) immunohistochemistry.Western blotting was performed to determine the levels of importin13 and bcl-2 proteins in EPs.The expression levels of IPO13, c-kit, telomerase, caspase3, and bax were lower in the EP tissue compared to normal endometrial tissue during the proliferation and secretion phases of the menstrual cycle (p<0.05).

View Article: PubMed Central - PubMed

Affiliation: Department of Obstetrics and Gynecology, 1st Affiliated Hospital, Chongqing Medical University, Chongqing, China.

ABSTRACT

Background: To investigate the expression levels of importin13 (IPO13), c-kit, CD146, telomerase, caspase-3, bcl-2 and bax in endometrial polyps (EPs).

Material/methods: We detected the mRNA expression levels of IPO13, c-kit, bcl-2 and bax in endometrial polyps (EPs) using real-time PCR. We detected the protein expression levels of IPO13, telomerase, CD146, caspase-3, bcl-2 and bax in EPs using S-P (Streptavidin-Peroxidase) immunohistochemistry. Western blotting was performed to determine the levels of importin13 and bcl-2 proteins in EPs.

Results: The expression levels of IPO13, c-kit, telomerase, caspase3, and bax were lower in the EP tissue compared to normal endometrial tissue during the proliferation and secretion phases of the menstrual cycle (p<0.05). The expression of CD146 was decreased in the EP tissue compared to the normal endometrial tissue during the proliferation phase of the menstrual cycle (p<0.05). The expression of bcl-2 was increased in the EP tissue compared to the normal endometrial tissue during the proliferation and secretion phases of the menstrual cycle (p<0.05).

Conclusions: The expression levels of IPO13, c-kit, telomerase, caspase3, and bax were decreased; however, the expression of bcl-2 was increased in the EP tissue compared to the normal endometrial tissue. These findings suggest that the development of EPs is associated with the deregulated activities of the endometrial stem/progenitor cells and the decreased apoptosis of endometrial cells, with the latter being the major factor involved in the development of EPs.

Show MeSH
Related in: MedlinePlus